{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:40:10Z","timestamp":1792096810502,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34HL123586"],"award-info":[{"award-number":["R34HL123586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001070"],"award-info":[{"award-number":["UL1TR001070"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.chest.2021.05.031","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T11:35:55Z","timestamp":1621769755000},"page":"1340-1349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis"],"prefix":"10.1016","volume":"160","author":[{"given":"Elliott D.","family":"Crouser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbaros Selnur","family":"Erdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinn M.","family":"Hade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"155","key":"10.1016\/j.chest.2021.05.031_bib1","doi-asserted-by":"crossref","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.chest.2021.05.031_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20696.1","article-title":"Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns","volume":"8","author":"Judson","year":"2019","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.chest.2021.05.031_bib3","doi-asserted-by":"crossref","first-page":"2000767","DOI":"10.1183\/13993003.00767-2020","article-title":"Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study","volume":"56","author":"Rossides","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2021.05.031_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on\u00a0quality of life in a sarcoidosis clinic: the\u00a0results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2021.05.031_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1164\/ajrccm.158.2.9712095","article-title":"Hypersensitivity pneumonitis in peat moss processing plant workers","volume":"158","author":"Cormier","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2021.05.031_bib6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A\u00a0case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2021.05.031_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thx.43.7.516","article-title":"Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease","volume":"43","author":"Valeyre","year":"1988","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2021.05.031_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCP.0b013e328351f9d6","article-title":"Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFalpha drugs","volume":"18","author":"Ferrara","year":"2012","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.chest.2021.05.031_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cei.13388","article-title":"Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis","volume":"199","author":"Valdez-Miramontes","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.chest.2021.05.031_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200210-1154OC","article-title":"Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in\u00a0vivo and in\u00a0vitro","volume":"169","author":"Blanchet","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.05.031_bib11","doi-asserted-by":"crossref","first-page":"237185","DOI":"10.1155\/2008\/237185","article-title":"Nicotine enemas for active Crohn's colitis: an open pilot study","volume":"2008","author":"Ingram","year":"2008","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.chest.2021.05.031_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.12-0383","article-title":"Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis","volume":"143","author":"Julian","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2021.05.031_bib13","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s10753-019-01027-9","article-title":"Alpha7 nicotinic acetylcholine receptor alleviates inflammatory bowel disease through induction of AMPK-mTOR-p70S6K-mediated autophagy","volume":"42","author":"Shao","year":"2019","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.chest.2021.05.031_bib14","first-page":"971","article-title":"Activation of the alpha7 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2","volume":"9","author":"Zhang","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.chest.2021.05.031_bib15","doi-asserted-by":"crossref","first-page":"100669","DOI":"10.1016\/j.conctc.2020.100669","article-title":"Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosis","volume":"20","author":"Hade","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"issue":"8","key":"10.1016\/j.chest.2021.05.031_bib16","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis: an official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2021.05.031_bib17","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.chest.2021.05.031_bib18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1378\/chest.11-2027","article-title":"Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis","volume":"142","author":"Erdal","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2021.05.031_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3999(02)00392-6","article-title":"Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale","volume":"54","author":"Michielsen","year":"2003","journal-title":"J\u00a0Psychosom Res"},{"issue":"7","key":"10.1016\/j.chest.2021.05.031_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2021.05.031_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0149-2918(00)80089-2","article-title":"American translation, modification, and validation of the St. George\u2019s Respiratory Questionnaire","volume":"22","author":"Barr","year":"2000","journal-title":"Clin Ther"},{"issue":"12","key":"10.1016\/j.chest.2021.05.031_bib22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","article-title":"Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference","volume":"184","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.05.031_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0140-6736(90)90014-V","article-title":"Randomisation and baseline comparison in clinical trials","volume":"335","author":"Altman","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.chest.2021.05.031_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.201709-1845OC","article-title":"Reliability and minimal clinically important differences of forced vital capacity: results from the Scleroderma Lung Studies (SLS-I and SLS-II)","volume":"197","author":"Kafaja","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2021.05.031_bib25","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the ACCESS study","volume":"22","author":"Yeager","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.chest.2021.05.031_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1378\/chest.08-1876","article-title":"Changes in chest roentgenogram of\u00a0sarcoidosis patients during a clinical\u00a0trial of infliximab therapy: comparison of different methods of\u00a0evaluation","volume":"136","author":"Baughman","year":"2009","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2021.05.031_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.05.031_bib28","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","article-title":"No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis","volume":"138S","author":"Broos","year":"2018","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.05.031_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1378\/chest.88.5.687","article-title":"Daily vs\u00a0alternate day prednisone therapy for stage II sarcoidosis","volume":"88","author":"Spratling","year":"1985","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2021.05.031_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2021.05.031_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2021.05.031_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.chest.2021.05.031_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00408-015-9784-9","article-title":"Benefits of physical training in sarcoidosis","volume":"193","author":"Strookappe","year":"2015","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.chest.2021.05.031_bib34","first-page":"2","article-title":"Patient reported outcome measures (PROMs) in sarcoidosis","volume":"34","author":"Thunold","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.chest.2021.05.031_bib35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1152\/jn.00740.2010","article-title":"Nicotine excites hypothalamic arcuate\u00a0anorexigenic proopiomelanocortin neurons and\u00a0orexigenic neuropeptide Y neurons:\u00a0similarities and differences","volume":"106","author":"Huang","year":"2011","journal-title":"J\u00a0Neurophysiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221009624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221009624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:36:53Z","timestamp":1757925413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221009624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0012369221009624"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.05.031","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}